Alemtuzumab in the up-front setting
Matthew Kaufman, Kanti R RaiLong Island Jewish Medical Center, New Hyde Park, NY, USAAbstract: Alemtuzumab is a humanized chimeric monoclonal antibody targeting CD52. Although this agent already has an important role in the treatment of chronic lymphocytic leukemia (CLL), many of its uses are still...
Kaydedildi:
Asıl Yazarlar: | , |
---|---|
Materyal Türü: | Kitap |
Baskı/Yayın Bilgisi: |
Dove Medical Press,
2008-04-01T00:00:00Z.
|
Konular: | |
Online Erişim: | Connect to this object online. |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
Yer Numarası: |
A1234.567 |
---|---|
Kopya Bilgisi 1 | Kütüphanede |